Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Schmid, Maximilian P. [VerfasserIn]   i
 Held, Thomas [VerfasserIn]   i
 Lang, Kristin [VerfasserIn]   i
 Herfarth, Klaus [VerfasserIn]   i
 Hörner-Rieber, Juliane [VerfasserIn]   i
 Harrabi, Semi B. [VerfasserIn]   i
 Moratin, Julius [VerfasserIn]   i
 Freudlsperger, Christian [VerfasserIn]   i
 Plath, Karim [VerfasserIn]   i
 Debus, Jürgen [VerfasserIn]   i
 Adeberg, Sebastian [VerfasserIn]   i
Titel:Intensity modulated radiotherapy with carbon ion radiotherapy boost for acinic cell carcinoma of the salivary glands
Verf.angabe:Maximilian P. Schmid, Thomas Held, Kristin Lang, Klaus Herfarth, Juliane Hörner-Rieber, Semi B. Harrabi, Julius Moratin, Christian Freudlsperger, Karim Zaoui, Jürgen Debus and Sebastian Adeberg
E-Jahr:2021
Jahr:2 January 2021
Umfang:9 S.
Fussnoten:Gesehen am 04.02.2021
Titel Quelle:Enthalten in: Cancers
Ort Quelle:Basel : MDPI, 2009
Jahr Quelle:2021
Band/Heft Quelle:13(2021,1) Artikel-Nummer 124, 9 Seiten
ISSN Quelle:2072-6694
Abstract:Aim: to report clinical outcome in patients with acinic cell carcinoma of the salivary glands treated with intensity-modulated radiotherapy (IMRT) and carbon ion radiotherapy (CIRT) boost. Materials and Methods: all patients with acinic cell carcinoma of the salivary glands treated at the Heidelberg Ion-Beam Therapy Center were considered for this retrospective analysis. All patients received a CIRT boost with 18–24 Gy radiobiologic effectiveness (RBE)-weighted dose in 3 Gy RBE-weighted dose per fraction followed by IMRT, with 50–54 Gy in 2 Gy per fraction. Disease outcome was evaluated for local (LR), nodal (NR), distant recurrence (DR), and disease-free (DFS) and overall survival (OS). Morbidity was scored based on Common Terminology Criteria for Adverse Events (CTCAE) version 5. Descriptive statistics and the Kaplan-Meier method were used for analysis. Results: fifteen patients were available for analysis. Median follow-up after radiotherapy was 43 months. Six patients were treated for primary disease and nine for recurrent disease. Eight patients were treated with radiotherapy for macroscopic disease. Disease recurrence was observed in four patients: 1 LR, 2 NR, and 2 DR; 5-year local control, DFS, and OS were 80%, 52%, and 80%, respectively. No radiotherapy-related G3-5 morbidity was observed. Conclusion: In acinic cell carcinoma, IMRT with carbon ion radiotherapy boost leads to excellent results after R1-resection and is a promising treatment modality for definitive treatment in inoperable patients.
DOI:doi:10.3390/cancers13010124
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.3390/cancers13010124
 Volltext: https://www.mdpi.com/2072-6694/13/1/124
 DOI: https://doi.org/10.3390/cancers13010124
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:C12
 head and neck cancer
 particle therapy
K10plus-PPN:1747417106
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68688574   QR-Code
zum Seitenanfang